Skip to playerSkip to main content
CNW Group
  • 15 years ago
Prolia (denosumab) est approuvé par Santé Canada pour le traitement des femmes ménopausées souffrant d'ostéoporose et présentant un risque élevé de fracture

Category

🗞
News
Comments

Recommended

Combined Heat and Power project at Campbell Canada
CNW Group
10 years ago
Kimberley Seldon: Happy Renovating!
CNW Group
10 years ago
Merck Receives Approval of ZEPATIER™
CNW Group
10 years ago
CHFA Reveals the Top Five New Natural Health Trends For 2016
CNW Group
10 years ago
Holiday Travel Tips to Help Families Through Security
CNW Group
10 years ago
BC companies pledge to change the Face of Leadership™ with The Minerva Foundation for BC Women
CNW Group
10 years ago
Michael "Pinball" Clemons tackles pneumococcal pneumonia
CNW Group
10 years ago
Commissionaires Services
CNW Group
10 years ago
There are many ways to thank veterans
CNW Group
10 years ago
Calling all mothers to participate in ONE DROP's online fundraising campaign
CNW Group
10 years ago
Canadian Society of Corporate Secretaries (CSCS) Announces Winners
CNW Group
10 years ago
Canadian Cheese Rolling Festival keeps growing
CNW Group
10 years ago
La campagne #golfcanadagolf r?unit les Canadiens
CNW Group
11 years ago
#GolfCanadaGolf Campaign Unites Canadians' Passion for Golf
CNW Group
11 years ago
Second Harvest Hero campaign
CNW Group
11 years ago
Simple Ways To Rethink Your Drink
CNW Group
11 years ago
Sparkling 7 Day Challenge
CNW Group
11 years ago
The Ultimate Weber Grills dock party
CNW Group
11 years ago
Canadians help save lives of vulnerable mothers and children
CNW Group
11 years ago
Toronto Pearson réaménagement de l'Aérogare 3
CNW Group
11 years ago
Toronto Pearson redevelopment of Terminal 3
CNW Group
11 years ago
Pfizer Préférence
CNW Group
11 years ago
Introducing the new Pfizer Préférence program
CNW Group
11 years ago
Introducing CNW’s Content Centre
CNW Group
11 years ago
Holiday Travel Tips to Help Families Through Security
CNW Group
10 years ago